SCR-LIP-000249 · Claim · machine-readable JSON →

LIPLEG is a planned multicentre investigator-blinded RCT randomising 405 women with painful lipedema (2:1) to liposuction plus CDT versus CDT alone, with the primary endpoint being a ≥2-point pain reduction on the NRS at 12 months, but the article is a study protocol with no results yet (recruitment started December 2020; NCT04272827).

Claim at a glance

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31

Evidence over time

A randomised controlled multicentre investigator-blinded clinical trial comparing efficacy and safety of surgery versus complex physical decongestive therapy for lipedema (LIPLEG) — Podda et al. (2021) ✓ verified — contextual · rct · 2021 · reading confidence: high
“Protocolo de estudo — sem resultados disponíveis ainda; recrutamento iniciado dezembro 2020; último paciente/última visita esperado verão 2025 (NCT04272827)”
This is a published RCT protocol directly designed to evaluate liposuction efficacy and safety in lipedema, but it reports no outcome data yet, so it provides methodological context rather than evidence supporting or contradicting the quest

Populationwomen with painful lipedema

Conditionlipedema

Exposureliposuction plus CDT

ComparatorCDT alone

Outcome≥2-point NRS pain reduction at 12 months

Scopeauto-ingested from Layer 1 surveillance

Auto-ingested single source; not yet human-reviewed.